GNAQ and hypertensive disorder: Continuous or repeated agonist stimulation of Gαq/11-coupled GPCR signaling can have adverse effects on arterial smooth muscle cells (2, 12), suggesting that understanding the regulation of arterial smooth muscle Gαq/11 signaling might facilitate the identification of novel targets for the treatment of hypertension.